[DHSS Logo] Delaware Health & Social Services Division of Public Health Laboratory LPAC - November 14, 2008 Shiga Toxin Producing Escherichia coli Debbie Rutledge, Clinical Microbiology Lab Manager Background • In 1999- 100,000 illnesses, 3200 hospitalizations, 91 deaths in US; • Asymptomatic shedding, non-bloody diarrhea, hemorrhagic colitis, HUS; • contaminated food or H20 & infected animals or persons; • O157 most recognized- others just as common; • >100 serotypes, O157 sorbitol negative, Others undistinguishable. Conventional Culture Testing for STEC • Culture media – Sorbitol-MacConkey (SMAC) agar – Cefixime-Tellurite (CT)-SMAC – Chrom agar • Disadvantages – Some E. coli O157:H7 can have unusual biochemical characteristics (e.g., sorbitol positive) – Low numbers may not be isolated – Sensitivity of culturing for E. coli O157:H7 may be low (50-60%) – Misses non-O157:H7 STEC STEC Non culture methods • 1995, FDA cleared first rapid assay for detection of STEC from stools. • EIA – Enzyme Immunoassay for detection of stx 1 & 2. • Labs –rely on these tests rather than culture methods. • Lose epidemiologic and surveillance information without isolate. Non culture methods • Pros: – Advantages for care of the individual patient. – Rapid and easy to perform. – Enables detection of non-O157 STEC isolates. • Cons: – False positives – reportable disease. – Inability to easily obtain critical isolates needed for public health surveillance activities. • Antimicrobial resistance. • PulseNet molecular subtyping. • Detection of novel or altered strain types . STEC in Delaware Pathogen Detection and Characterization DPHL STEC Recommendations • Clinical labs- submit shigatoxin positive broths and/or original stool; • Tests original and new broths –stx 1 & 2 by EIA or PCR; • Sub positive broths – tests up to 20 colonies for stx 1 & 2 by EIA or PCR; • Look for O157 and screen colonies with RIM E.coli antisera; • Confirm biochemically- ID of E.coli. Serotyping & PFGE • Serotype for O157 & top 6 “O” groups (026,045, 0103,0111,0121,0145); • If unable to serotype –send to CDC; • Pulse-Field Gel Electrophoresis- within 4 days from receipt- Pulsenet; • Analyze gels and send to CDC Pulsenet database. Conclusions • Timely laboratory diagnosis of STEC illness – prevent inappropriate treatment . – allow for supportive care to prevent HUS. – Requires communication between hospital and state PHLs to ensure optimal testing. • Including PCR testing to conventional testing algorithms - guide appropriate and cost effective public health efforts and focuses resources on optimal STEC recovery . • The recover of STEC isolates is essential to the tracking of cases and detection of outbreaks. – Enables prompt PFGE subtyping and further characterizations. – Allows for public health interventions (ie. Recalls) to prevent additional infections. Acknowledgements • DPHL Clinical Microbiology Lab Staff • Denise Toney, VA Division of Consolidated Laboratories • 2008 APHL STEC Subcommittee • Susan Shore, DPH Epidemiology